• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A further strategy to combat the high price of anticancer drugs.

作者信息

Prasad Vinay, De Jesús Kevin, Mailankody Sham

机构信息

Division of Hematology and Medical Oncology, Knight Cancer Institute, Department of Preventive Medicine and Public Health, and Center for Health Care Ethics, Oregon Health and Science University, Portland, Oregon 97239, USA.

Ponce Health Sciences University-School of Medicine, P.O. BOX 7004, Ponce, Puerto Rico 00716-2347, USA.

出版信息

Nat Rev Clin Oncol. 2017 Oct;14(10):629. doi: 10.1038/nrclinonc.2017.137. Epub 2017 Aug 22.

DOI:10.1038/nrclinonc.2017.137
PMID:28829055
Abstract
摘要

相似文献

1
A further strategy to combat the high price of anticancer drugs.对抗抗癌药物高昂价格的进一步策略。
Nat Rev Clin Oncol. 2017 Oct;14(10):629. doi: 10.1038/nrclinonc.2017.137. Epub 2017 Aug 22.
2
A further strategy to combat the high price of anticancer drugs.
Nat Rev Clin Oncol. 2017 Oct;14(10):629. doi: 10.1038/nrclinonc.2017.136. Epub 2017 Aug 22.
3
Rising cost of anticancer drugs in Australia.澳大利亚抗癌药物成本不断上涨。
Intern Med J. 2014 May;44(5):458-63. doi: 10.1111/imj.12399.
4
[Anticancer agents: has the maximal tolerated price been reached?].[抗癌药物：是否已达到最大耐受价格？]
Bull Cancer. 2012 Sep;99(9):808-10. doi: 10.1684/bdc.2012.1609.
5
[Impact of the expiry of the patent on quality and price of medicines at hospital: Study of five anticancer drugs from 2008 to 2015 at the Assistance publique-Hôpitaux de Paris].
Ann Pharm Fr. 2017 Jan;75(1):59-66. doi: 10.1016/j.pharma.2016.06.002. Epub 2016 Jul 14.
6
The high price of anticancer drugs: origins, implications, barriers, solutions.抗癌药物的高昂价格：起源、影响、障碍、解决方案。
Nat Rev Clin Oncol. 2017 Jun;14(6):381-390. doi: 10.1038/nrclinonc.2017.31. Epub 2017 Mar 14.
7
Efficacy, safety, and cost of new anticancer drugs. Price needs to be evaluated against effectiveness.新型抗癌药物的疗效、安全性及成本。价格需与疗效相权衡。
BMJ. 2002 Nov 30;325(7375):1302; author reply 1302.
8
Possible Insufficiency of Generic Price Competition to Contain Prices for Orally Administered Anticancer Therapies.可能的通用价格竞争不足以控制口服抗癌疗法的价格。
JAMA Intern Med. 2017 Nov 1;177(11):1679-1680. doi: 10.1001/jamainternmed.2017.2788.
9
Rising Cost of Anticancer Medications in the United States.美国抗癌药物成本的上升
Ann Pharmacother. 2017 Aug;51(8):706-710. doi: 10.1177/1060028017702406. Epub 2017 Mar 24.
10
Risk of incremental toxicities and associated costs of new anticancer drugs: a meta-analysis.新抗癌药物增量毒性的风险和相关成本：一项荟萃分析。
J Clin Oncol. 2014 Nov 10;32(32):3634-42. doi: 10.1200/JCO.2014.55.8437. Epub 2014 Sep 29.

引用本文的文献

1
Estimating the effect of optimizing anticancer drug vials on medical costs in Japan based on the data from a cancer hospital.基于癌症医院的数据估计优化抗癌药物小瓶对日本医疗费用的影响。
BMC Health Serv Res. 2020 Nov 9;20(1):1017. doi: 10.1186/s12913-020-05822-1.
2
"Real world survey" of hydrogen-controlled cancer: a follow-up report of 82 advanced cancer patients.氢气控癌的“真实世界研究”：82例晚期癌症患者的随访报告
Med Gas Res. 2019 Jul-Sep;9(3):115-121. doi: 10.4103/2045-9912.266985.

本文引用的文献

1
A further strategy to combat the high price of anticancer drugs.
Nat Rev Clin Oncol. 2017 Oct;14(10):629. doi: 10.1038/nrclinonc.2017.136. Epub 2017 Aug 22.
2
The high price of anticancer drugs: origins, implications, barriers, solutions.抗癌药物的高昂价格：起源、影响、障碍、解决方案。
Nat Rev Clin Oncol. 2017 Jun;14(6):381-390. doi: 10.1038/nrclinonc.2017.31. Epub 2017 Mar 14.
3
Target prices for mass production of tyrosine kinase inhibitors for global cancer treatment.用于全球癌症治疗的酪氨酸激酶抑制剂大规模生产的目标价格。
BMJ Open. 2016 Jan 27;6(1):e009586. doi: 10.1136/bmjopen-2015-009586.
4
The accelerated approval of oncologic drugs: lessons from ponatinib.肿瘤药物的加速批准：普纳替尼的经验教训。
JAMA. 2014;311(4):353-4. doi: 10.1001/jama.2013.284531.